The influence of COVID-19 pandemic on secondary prevention in non-COVID patients with cardioembolic stroke
Introduction: Since March 2020, when the World Health Organization declared the global pandemic of the Coronavirus disease 2019 (COVID-19), an era of great challenges for the entire healthcare system has begun. A new organization of the healthcare system was needed to balance care not only for cases...
Saved in:
Main Authors: | Lučić-Prokin Aleksandra L., Bogdanović Milan M., Pustahija Tatjana L., Stamenković Marija S. |
---|---|
Format: | Article |
Language: | English |
Published: |
Srpsko lekarsko drustvo
2024-01-01
|
Series: | Hospital Pharmacology |
Subjects: | |
Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/2334-9492/2024/2334-94922403529L.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Direct oral anticoagulants for stroke prevention and risk of bleeding
by: Tomoyuki Kawada
Published: (2025-02-01) -
The Role of Atrial Fibrillation and Oral Anticoagulation Status in Health‐Related Quality of Life 12 Months After Ischemic Stroke or TIA
by: Manuel C. Olma, et al.
Published: (2025-01-01) -
Prospects of oral anticoagulant therapy in patients with atrial fibrillation and chronic anemia: a narrative review
by: Tatyana S. Degtyareva, et al.
Published: (2024-12-01) -
Left Atrial Appendage Occlusion: Expanding Indications and New Developments
by: Grant W. Reed, MD, MSc, et al.
Published: (2025-01-01) -
Efficacy and Safety of New Oral Anticoagulants versus Warfarin in the Resolution of Atrial Fibrillation with Left Atrial/Left Atrial Appendage Thrombus: A Systematic Review and Meta-Analysis
by: Guan-lian Mo, et al.
Published: (2025-01-01)